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Abstract
Type 1 diabetes (T1D) is a disorder characterized by auto-immune destruction of beta cells,
the cells in the pancreas that produce insulin. After destruction of these cells, patients often become
insulin-dependent and rely on subcutaneous insulin injections for the rest of their lives. The goal
of this study was to learn more about the underlying metabolic conditions that could result in
increased TID susceptibility. The LEW.1WR1 rat models develop T1D upon every other day
injection of polyinosinic:polycytidylic acid (PIC), a dsRNA molecule that stimulates the immune
response. The susceptibility window of inducible T1D in the LEW rat occurs between 21-35 days
(3-5 weeks) of life, which is a similar life stage of the onset of human T1D (peak age of onset is
14 years old).
The objective of this study was to compare the size and number of insulin-stained
pancreatic islets in 1WR1 rats treated with PIC with control rats during disease induction. Data
was collected at the time point before the rats develop insulin-dependent TID (6 days, 7 hours into
induction protocol). Terminal Fasting Blood Insulin and Terminal Fasting Blood Glucose
measurements were taken to characterize the condition of the rats at the time point chosen. Results
show the 1WRI rats had blood glucose levels trending toward hyperglycemic levels despite having
significantly higher blood insulin levels. Using immunohistochemistry, we were able to visualize
pancreatic islet infiltration by CD3 and CD68 stained cells. After averaging the results of the blind
scorers, we found that the 1WR1 rats tended to have infiltration scores in the 2-3 range for the
CD3 stain and between 1-1.5 for the CD68 stain. We also found that the 1WR1 rats had a
significantly lower number of extra small, small, and total number of islets as compared to the
control group. From these results, we concluded that the rats were not undergoing insulitis at the
chosen time point and had reduced numbers of islets prior to the onset of full-blown insulitis.
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Introduction
Type 1 diabetes (T1D), which comprises approximately 10% of all diabetes mellitus, is a
disorder characterized by the autoimmune destruction of insulin-producing pancreatic beta cells.
B-cell death is mediated by T-cells of the immune system. After the destruction of these cells,
patients often become insulin-dependent and rely on subcutaneous insulin injections for the rest of
their lives. TID is garnering increasing attention due to its growing prevalence worldwide. Many
patients are beginning to develop “double diabetes”, a condition in which T1D patients develop
the weight gain and insulin resistance characteristic of Type 2 diabetes. 1 This condition often
requires higher insulin intake, which exacerbates the weight problem by leading to additional
weight gain. This observation has led to a recent interest in understanding if there are underlying
metabolic dysfunctions that could lead to increased T1D susceptibility. Because the disease
progresses over the course of many years, early pre-diabetic events that lead to T1D have not been
well studied.
Our lab studies the LEW.1WR1 (1WR1) rat, an inducible T1D rat model with a class 2
MHC haplotypes of RT1B/Du.2 The susceptibility of 1WR1 rat models is linked to FAT10
overexpression, a ubiquitin-like protein that plays an unclear role in the regulation of lipid
metabolism. A previous study found 1WR1 rats spontaneously develop T1D at a rate of 2% and
can develop it at a rate of 100% upon immunological stimulation with polyinosinic:polycytidylic
acid (PIC).2 PIC is a toll-like receptor 3 (TLR3) ligand that stimulates the immune response. It has
been shown that 1WR1 rats can develop diabetes in a 21-35-day window in response to injection
with a low dose of PIC (1.0 μg/g body wt, 3 times per week).2 The clinical symptoms of T1D seen
in LEW.1WR1 rats is polyuria, weight loss, increased water consumption, glycosuria, and large
amounts of urinary ketones. An analysis of histological slides reveals inflammatory insulitis in
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newly diagnosed diabetic animals and “end-stage insulitis” in animals with chronic diabetes. 2 We
have observed that these rats have increased triglyceride and phosphatidylcholine in their islets
and increased fasting circulating insulin levels at day 6 or 8 of the induction protocol when
compared to Wistar Furth rats (an RT1μ haplotype control).3,4,5,6 Eberwine et al. also observed that
on day 7 and 9 of induction, LEW.1WR1 rats displayed increased insulin islet transcripts,
suggesting a change in beta cell function.7 They also found an increase in total T-cell abundance,
focusing particularly on a subpopulation of Vb13+ T cells required for diabetes induction. 5 Based
off these observations, Eberwine et al. hypothesize that the rats may be upregulating insulin gene
transcription as a compensatory mechanism to T-cell mediated β-cell death. The results of their
study also provide more insight into the immediate functional consequence of T-cell inﬁltration in
the islet and a progressive decline in b-cell mass/function that persists for multiple days before
hyperglycemia develops from T1D.5
Our observations led us to hypothesize that these rodents overproduce insulin in response
to PIC, leading to beta cell fatigue and the eventual autoimmune destruction of the beta cell. We
sought to analyze changes in pancreatic islet size and distribution as well as immune cell
infiltration in relation to the metabolic status of these animals at 6 days 7 hours into induction
protocol to observe if there are significant shifts in islets or insulitis at this time point that lead to
increased susceptibility to T1D compared to resistant rodents. We chose this as a prior to insulitis
but shortly after daily injection time point to observe relevant cytokine and chemokine changes.
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Materials and Methods
Chemicals
10x Phosphate Buffered Saline was obtained from Thermo Fisher Scientific (Waltham,
MA). Vacci grade Polyinosinic:polycytidylic acid (PIC) was obtained from Invivogen (San Diego,
CA).
Animals
4 groups of rats were tested: the control and treated groups of the LEW.1WR1 rat model,
which was our model of interest, and the control and treated groups of the LEW/SsNHsd rat
models, which are resistant to T1D. LEW/SsNHsd (SsNHsd) and LEW.1WR1 (1WR1) rats are
obtained at 18 days old from Envigo (Indianapolis, IN) and Biomere (Worcester, MA)
respectively. LEW/SsNHsd (Resistant), and LEW.1WR1 (Susceptible) rats were approximately 4
weeks old at the time of harvest. Animals were housed in UAH Vivarium maintained with a 12hour light-dark cycle. Protocols were approved by UAH IACUC. LEW.1WR1 rats are susceptible
to inducible Type 1 diabetes onset with the administration 1μg/g body mass PIC injections every
other day for two weeks. We chose to understand changes prior to onset and looked at changes
midway. Body mass was measured before injection. The rats were induced for 6 days with every
other day injection interval for treated and PBS (control).
Blood Marker Measurements
The terminal fasting blood glucose level was measured using Alpha Tracks 2 meter by
Zeotis. (Parsippany.NJ). The metabolic hormone, chemokines, and cytokines levels are measured
in heparinized plasma prepared according to the Eve Technologies recommended protocol. Blood
hormone and cytokine level are analyzed using Rat Metabolic Hormone 10-Plex Discovery Assay

CHARACTERIZING THE INSULIN STAINING OF LEW.1WR1 RATS

7

and Rat Cytokine 27-Plex Discovery Assay are performed by Eve technologies Calgary, AB,
Canada.
Histopathology
Formalin fixed pancreases were sent to Histowiz (Brooklyn, New York). Formalin-fixed,
paraffin-embedded pancreatic tissues of each animal were sectioned (4 μm) and stained against
CD68, CD3, or insulin. A CD3 stain was performed to identify t-cell levels, and a CD 68 stain was
performed to identify macrophages, monocytes, or dendritic cells. An insulin stain was performed
to determine the relative size of each islet. The resulting digitized slides were scored based on
histological appearance. Blind scorers were recruited to score the level of intensity of the CD3+
and CD68+ staining and to count the total number of extra small, small, medium, and large islets.
CD3
Blind scorers analyzed ten representative islets from each stained section to characterize
islet T cell infiltration after 6 days and 7 hours of the induction protocol. Islets were scored on a
scale from 1 to 4, with 1 indicating a low level of infiltration and 4 indicating a high level of
infiltration. A darker CD 3 stain indicates a higher number of t-cells. Typically, rats exhibiting
end-stage insulitis have t-cell scores in the 3 or 4 range.8
CD68
Blind scorers analyzed ten representative islets from each stained section to characterize
islet T cell infiltration after 6 days and 7 hours of the induction protocol. Islets were scored on a
scale from 1 to 4, with 1 indicating a low level of infiltration and 4 indicating a high level of
infiltration. A darker CD 68 stain indicates higher levels of macrophages, monocytes, or dendritic
cells. Their infiltration follows the destruction of beta cells by t cells, and their numbers are also
elevated in the 3 to 4 range during insulitis.8
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Insulin
Blind scorers were recruited to count the number of extra-small (XS), small (S), medium
(M), large (L), and total number of insulin-stained islets. The size chart used to score the size of
each islet is depicted in Figure 1 below. The total number of islets at each size was counted to
generate Figures 6-10 in the results section.

Figure 1. Islet Size Comparison. This figure shows the representative images of insulin-stained
islets at sizes extra-small (<10 mm), small (10-15 mm), medium (16-20 mm), and large (>20
mm). Magnification was at 2 x 500 μm.
Statistical Analysis
One-way ANOVA followed by Tukey’s test was performed using GraphPad Prism 7.04 (La Jolla,
CA).
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Results
Confirming the level of insulitis in the rats. Figure 2 shows the results of the CD3 stain. After
averaging the results of the blind scorers, we found that the 1WR1 rats tended to have infiltration
scores in the 2-3 range, which is slightly less than what we would expect during end-stage insulitis
and the transition to hyperglycemia. For the CD68 stain in Figure 3, we found that the values
ranged between 1-1.5, which is slightly less than the CD3 scores. The insulitis scores for the PIC
treated animals in both groups were higher than the control animals. It did not appear that the
pancreas of the treated animals had significantly infiltrated islets.
It is also observed in figure 4 that the 1WR1 rats had blood glucose levels nearing 150 mg/dL,
which is higher than the SsNHsd rats but less than the hyperglycemic levels expected in the case
of diabetes. The rats were still normoglycemic however in figure 5 the Terminal Fasting Blood
Insulin Concentration of the 1WR1 rat models showed significantly higher blood insulin levels
than their SsNHsd counterparts, whose values were so low that they fell outside the range of the
assay.
Semi-Quantitative analysis of insulin stained pancreatic islets. Figures 6-10 presents the results
for the quantification of insulin-stained islets of different sizes. On average, extra small islets were
below 10 millimeters, small islets were 10-15 millimeters, medium islets were 16-20 millimeters,
and large islets were greater than 20 millimeters. After compiling the results from the blind scorers,
we found that the 1WR1 rats showed a significantly lower number of extra small and small islets
compared to the control group. The 1WR1 rats also showed a lower number of total overall islets.
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Figure 2a and 2b. The treated rat groups appeared to have significantly higher infiltration
than both the control groups. 1a shows the representative micrographs of CD3 stained
pancreases. (A) to the top left is the LEW.1WR1-Control, (B) to the top right is LEW.1WR1Treated, (C) to the bottom left is LEW/SsNHsd-Control, and (D) to the bottom right is the
LEW/SsNHsd-Treated. 1b shows the quantification of scored islets from each group. Islets are
circled. n=8, 8, 4, & 8. Error bars reflect standard deviation. * indicates p< 0.05, ** indicates
p< 0.001, and **** indicates p< 0.00001.
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Figure 3a. and 3b. The CD68 stained cells are not heavily invading the islets of the rats at this
point during the T1D induction protocol. Figure 2a. shows representative micrographs of CD68
stained pancreas. (A) to the top left is the LEW.W1R1-Control, (B) to the top right is
LEW.W1R1-Treated, (C) to the bottom left is the LEW/SsNHsd-Control, and (D) to the bottom
right is LEW/SsNHsd-Treated. Figure 2b shows the quantification of scored islets from each
group. Islets are circled n= 4, 8, 8, & 8. Error bars reflect standard deviation. * indicates p<
0.05. The treated SsNHsd rats had significantly higher infiltration than the 1WR1 control rats.

A

B

CHARACTERIZING THE INSULIN STAINING OF LEW.1WR1 RATS

Figure 4. Fasting blood glucose for 1WR1 control group is significantly higher
than both LEW/SsNHsd groups. The Terminal Blood Glucose levels of rats from
both groups. Rats were fasted for 6 hours prior to collection. Error bars represent
a SD of n=8. * is p<0.05.
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Figure 5. The 1WR1 rats have a higher fasting blood insulin concentration than LEW/SsNHsd rats
at this time point. This figure shows the Terminal Fasting Blood Insulin concentration of rats from
both groups. #- LEW/SsNHsd controls had a large proportion of samples that were below the range
of the assay.
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Figure 6. The 1WR1 rats showed a significantly lower number of extra small islets as compared
to the SsNHsd rats. This figure shows the quantification of extra small insulin-stained islets. n=
4, 8, 8, & 8. Error bars reflect standard deviation. * indicates p< 0.05 ** indicates p< 0.001 and
*** indicates p< 0.0001.
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Figure 7. The 1WR1 rats showed a significantly lower number of small islets as compared to the
SsNHsd rats. This figure shows the quantification of small insulin-stained islets. n= 4, 8, 8, & 8.
Error bars reflect standard deviation. * indicates p< 0.05.

C

D

E
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Figure 8. The 1WR1 treated rats had a significantly lower number of medium-sized islets than the
LEW/SsNHsd treated rats. This figure shows the quantification of medium insulin-stained islets.
n= 4, 8, 8, & 8. Error bars reflect standard deviation. * indicates p< 0.05.
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Figure 9. No significant difference was seen in the number of large insulin-stained islets between
the different rat groups. This figure shows the quantification of large insulin-stained islets. n= 4,
8, 8, & 8. Error bars reflect standard deviation.
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Figure 10. The 1WR1 rats had a significantly lower number of total islets than the SsNHsd rats.
This figure shows the total number of islets for each rat group. n= 4, 8, 8, & 8. Error bars reflect
standard deviation. * indicates p< 0.05 ** indicates p< 0.001 and *** indicates p< 0.0001.
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Discussion
From epidemiological studies of Type 1 Diabetes, it has been shown that the incidence of
T1D increases in autumn and winter, suggesting the development of T1D-associated autoimmunity
having a synchronization with seasons. These factors strengthen the theoretical role environmental
or pathogenic stimulus may play in triggering the disease.9 Our rodent model is susceptible to a
virus/PIC triggered onset of T1D. This susceptibility has been shown to be related to the Type 1
Interferon receptor (cite)as well as an over expression of FAT10, but to date there have been no
studies to understand the condition of the islets prior to insulitis or the metabolic condition of the
animals in the susceptibility window.10
As noted in a review by Atkinson et. al., glucose fluctuations occur as an individual
approaches onset.9

It is unclear however how this relates to metabolic status prior to

autoimmunity. In the period of time during onset referred to as the honeymoon period, there seems
to be a remission characterized by reduced insulin requirements. This period is not well
characterized on a cellular level since biopsy of pancreas would be detrimental to the patient’s
ability to maintain normoglycemia. It has also been observed that increased T1D susceptibility is
marked by higher than threshold insulin release in response to a glucose tolerance test. 11 Based on
these observations, it seems as though increased insulin release is an important metabolic factor in
T1D susceptibility.
It has been confirmed that there is a genetic link behind the development of T1D. Decades
of research have revealed that nearly 40 loci are involved in influencing genetic susceptibly,
confirming the polygenetic nature of the disorder.9 In our studies we were interested in
understanding how genetic predisposition precipitating events and metabolic abnormality may be
having a combined effect to increase susceptibility. Previous studies attempting to map out the
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sequence of immunological events that occur prior to disease onset have revealed the importance
of certain immune cells in disease induction.12,13 The results of our CD3 and CD68 stain support
previous studies showing how the infiltration of CD3 cells tends to precede the increase in CD68
cells.12,13 The results of our CD68 stain also support a previous observation noting the important
role CD68 cells have in the process of insulitis during human T1D onset. 14 The results of each
stain also verified the time point we chose, as these rats have not yet developed full-blown TID
but are trending toward that point as is evidenced by the growing infiltration of immunocytes. 15
We have observed in these rodents that at day 12 a significant portion of the rats have 3-4
level infiltration of both CD3 and CD68 in their islets. In line with studies that our method was
adapted from, animals can have average insulitis scores of around 2.4 and maintain normoglycemia
during the time course of insulitis development.8 Most CD3+ and CD68+ staining was occurring
in the periphery of the islets in these animals which is consistent with the literature in human and
NOD mouse studies of the flow of immune cells into the pancreas during the development of
insulitis.
The results of Figure 4 and Figure 5 further characterize a portion of the metabolic
conditions of the rats at the chosen time point. These figures further prove how the 1WR1 rats are
metabolically different than the LEW/SsNHsd rats independent of approaching TID development.
This also shows that the rats have not reached the point of full-blown insulitis in the induction
protocol. These animals are showing a difference in blood insulin concentration independent of
PIC injection. Eberwine et. al.’s previous findings showed that insulin transcripts in the pancreas
of the 1WR1 rat are increased during induction.7 However this seems inconsistent with our
observation of lower numbers of islets in the 1WR1 rats. One reason that may explain this
inconsistency is the “honeymoon phase” and how maybe the lack of large islets could be indicative
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of a honey moon phase type of islet growth that we can’t be certain of without experiments
measuring markers of neogenic islets and characterizing islet size at more time points. 16
Conclusion and Future Directions
Based on the results of the CD3 stain, the 1WR1 rats are not undergoing significant insulitis
at this time point in the T1D induction protocol. With the low scoring levels of the CD68 stain, it
also appears as though the CD68 stained cells are not heavily invading the islets of the rats at the
chosen time point. These results were to be expected, as we chose a time point immediately before
the rats develop insulin-dependent TID. The results of the insulin staining were unexpected, as the
1WR1 showed a lower number of small and extra small islets as compared to the control group,
as well as a lower number of overall islets. However, the fact these rats have a lower total number
of islets yet higher fasting blood insulin levels may support the idea that (1) they have developed
a dampened response to the stimulus, or (2) their islets are beginning to die off, causing them to
release their insulin stores. Further research needs to be performed to verify these hypotheses.
In the future, it would be interesting to characterize total islets at multiple developmental
stages of this animal model to determine if their total islet mass increases over their life span. It
would also be interesting to utilize staining methods, such as K267, to assess the amount of
neogenic islets in the pancreas of these rat models in response to PIC.
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